By Dawood Fakhir (August 4, 2022, 3:51 PM BST) -- South African health care provider Mediclinic accepted an updated takeover bid on Thursday of £3.7 billion ($4.5 billion) from investors, including its biggest shareholder Remgro, the Linklaters-led consortium said.
Mediclinic, which is listed on the FTSE 250 index of the London Stock Exchange, accepted the offer from a consortium made up of South African investment company Remgro Ltd. and Switzerland-based MSC Mediterranean Shipping Co. SA.
Remgro, which is listed on the Johannesburg Stock Exchange, already holds nearly 45% of Mediclinic International's shares.
The investor group will therefore pay approximately £2 billion for the remaining shares and will then take the company...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!